News
12 May 2026
Frost & Sullivan’s 2026 Global Company of the Year
Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
4 June 2024
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs
Avance Clinical is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs.
28 May 2024
Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical
Avance Clinical has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS and rare diseases specialist CRO with extensive site relationships in the region.
9 May 2024
Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea – Seoul Office Announced at BIO Korea 2024
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open new clinical operations in Seoul, South Korea.
6 May 2024
Avance Clinical Welcomes Alex Kavros as Executive Vice President of Scientific & Regulatory Affairs
Avance Clinical, a leading Contract Research Organization (CRO) renowned for its innovative solutions in the biotech industry, is excited to announce the appointment of Dr Alex Kavros as the new Executive Vice President of Global Scientific & Regulatory Affairs.
3 May 2024
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend World Vaccine Congress in Washington DC (April 1-4, 2024) and share the latest clinical trial client news including the Uvax Bio announcement. (Booth #267)
16 April 2024
Introducing William Faria, the New Vice President of Biometrics at Avance Clinical
Avance Clinical proudly welcomes William Faria as its new Vice President of Biometrics. With an extensive background in data management within the biometrics sector, William brings a wealth of experience and a global perspective to his new role.
4 March 2024
Avance Clinical CEO Talks with SCRIP Intelligence about a New CRO Report and US Biotech Sector “Green Shoots”
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has today spoken with SCRIP Intelligence about their positive outlook for the US biotech sector following the J.P. Morgan Healthcare Conference and Biotech Showcase meetings.
22 February 2024
Avance Clinical and Ryght Partner to Bring Novel GenAI Technologies to Clinical Research Networks
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has today spoken with SCRIP Intelligence about their positive outlook for the US biotech sector following the J.P. Morgan Healthcare Conference and Biotech Showcase meetings.
8 January 2024
Frost & Sullivan Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner
Avance Clinical, the leading Australian and North American CRO for biotechs announced today that new industry analysis shows 60-65% of US biotechs face challenges identifying the right sized CRO partner that can deliver at every phase of their drug development program. The report found this directly affected clinical programs and budgets.
17 November 2023
Avance Clinical Strengthens Asia-Pacific Network with Digital Technology Company JNPMEDI INC
Avance Clinical, the Australian and North American market-leading CRO for biotechs, has signed a strategic technology MOU with leading Korean decentralized clinical trials (DCTs) and eClinical technology company JNPMEDI Inc.
23 October 2023
Avance Clinical Finalist In The 61st Australian Export Awards 2023
Avance Clinical, the award-winning Australian and North American market leading CRO for biotechs, has again been recognized for its contribution to International Health in the 61st Australian Export Awards 2023.
19 October 2023
Avance Clinical Invited To Brief 45 Korean Biotechs On Their Globalready Drug Development Pathway From Korea And Australia To The Us
Avance Clinical was asked to present their GlobalReady drug development solution to more than 45 Korean biotechs and pharmaceutical companies in Seoul, Korea as part of a special symposium at KoNECT Korea Conference.
Proven industry
experience & expertise
800+
Studies in the past 10 years
500+
Experienced team members
33k+
Participants past 10 years
30
Years of CRO experience